Weight-loss drugs market competition intensifies globally

Two big drug companies, Novo Nordisk and Eli Lilly, are competing to sell weight-loss medicines.

Novo recently launched a cheaper pill version of its drug, while Eli Lilly is about to get approval for its own pill.

Both companies are trying to make more of these drugs because many people want them.

The drugs are expensive, but prices might go down when other companies can make similar versions.

This is important because lots of people around the world are struggling with weight and related health problems.

The companies are also working on new, even better weight-loss drugs.